Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The New Era of Multiple Sclerosis Therapeutics.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Neuroinflammation: The role and consequences.
Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
TNFRSF1A polymorphisms and MS: Statistical signals transform into pathogenetic mechanisms.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca(2+) release from acidic Ca(2+) stores.
Infectious mononucleosis.
Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.

Pages